elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36373029-BD3D8819-7032-4B0A-890D-7C778C1BFB15
Q36373029-BD3D8819-7032-4B0A-890D-7C778C1BFB15
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36373029-BD3D8819-7032-4B0A-890D-7C778C1BFB15
Improvement of Fabry Disease-Related Gastrointestinal Symptoms in a Significant Proportion of Female Patients Treated with Agalsidase Beta: Data from the Fabry Registry.
P2860
Q36373029-BD3D8819-7032-4B0A-890D-7C778C1BFB15
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36373029-BD3D8819-7032-4B0A-890D-7C778C1BFB15
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
32385700a612796ad3d47318145406c5e13e8f86
P2860
Patients with Fabry Disease after Enzyme Replacement Therapy Dose Reduction and Switch-2-Year Follow-Up.